BUSSINI, LINDA
 Distribuzione geografica
Continente #
NA - Nord America 1.358
AS - Asia 925
EU - Europa 284
SA - Sud America 184
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 22
OC - Oceania 1
Totale 2.833
Nazione #
US - Stati Uniti d'America 1.318
SG - Singapore 465
CN - Cina 180
BR - Brasile 139
VN - Vietnam 125
IT - Italia 100
HK - Hong Kong 40
CA - Canada 26
IN - India 25
FI - Finlandia 24
GB - Regno Unito 24
IE - Irlanda 24
DE - Germania 22
FR - Francia 19
NL - Olanda 18
MY - Malesia 15
ES - Italia 11
CO - Colombia 9
EC - Ecuador 9
PL - Polonia 8
AR - Argentina 7
IQ - Iraq 7
PE - Perù 7
ZA - Sudafrica 7
BD - Bangladesh 6
EG - Egitto 6
ID - Indonesia 6
JP - Giappone 6
KR - Corea 6
MX - Messico 6
SA - Arabia Saudita 6
AT - Austria 5
TR - Turchia 5
VE - Venezuela 5
BG - Bulgaria 4
BH - Bahrain 4
CL - Cile 4
PH - Filippine 4
RU - Federazione Russa 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
GR - Grecia 3
IR - Iran 3
MA - Marocco 3
PK - Pakistan 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
GT - Guatemala 2
IL - Israele 2
JO - Giordania 2
SK - Slovacchia (Repubblica Slovacca) 2
UA - Ucraina 2
AM - Armenia 1
AU - Australia 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 2.774
Città #
Dallas 431
Singapore 171
Ashburn 154
San Jose 92
The Dalles 67
Santa Clara 52
Beijing 51
Ho Chi Minh City 46
Los Angeles 41
Shanghai 41
New York 36
Hong Kong 35
Milan 34
Boardman 32
Dublin 23
Helsinki 22
Hanoi 19
Buffalo 16
São Paulo 14
Chennai 13
Chicago 10
Kuala Lumpur 10
Amsterdam 9
Haiphong 8
London 8
Rio de Janeiro 8
Rome 8
Atlanta 7
Council Bluffs 7
Cuenca 7
Toronto 7
Cairo 6
Da Nang 6
Genoa 6
Montreal 6
Phoenix 6
Boston 5
Brooklyn 5
Orem 5
Queens 5
Riverside 5
Seattle 5
São Luís 5
Warsaw 5
Belfast 4
Bắc Ninh 4
Charlotte 4
Denver 4
Jeddah 4
Naples 4
Philadelphia 4
Ankara 3
Bologna 3
Can Tho 3
Chapel Hill 3
Charlemont 3
Frankfurt am Main 3
Grumo Nevano 3
Louisville 3
Manama 3
Medellín 3
Mexico City 3
Paris 3
Ribeirão Preto 3
Sacramento 3
Santiago 3
Sofia 3
Tashkent 3
Amman 2
Ancona 2
Arequipa 2
Athens 2
Baghdad 2
Barcelona 2
Bekasi 2
Belo Horizonte 2
Bogotá 2
Boydton 2
Brasília 2
Bristol 2
Buk-gu 2
Buon Ma Thuot 2
Cao Lanh 2
Chester Springs 2
Curitiba 2
Des Moines 2
Dongdaemun-gu 2
Dubai 2
Durban 2
Emden 2
Foz do Iguaçu 2
Fremont 2
Glasgow 2
Go Vap 2
Greensboro 2
Guadalajara 2
Guiyang 2
Hamburg 2
Hangzhou 2
Itajaí 2
Totale 1.692
Nome #
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 439
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 186
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections 129
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 107
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 93
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS‐CoV‐2 infection 92
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 71
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 68
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 61
Distinct chromosomal mutation associated with cefiderocol resistance in Acinetobacter baumannii: a combined bioinformatics and mass spectrometry approach to unveil and validate the in vivo-acquired chemoresistance 57
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 57
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 54
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 54
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 52
Dialysis-associated infection prevention and surveillance trial: an easy, feasible and effective bundle for infection prevention 52
ESCMID COVID-19 living guidelines: drug treatment and clinical management 50
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 50
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization 49
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 48
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 48
What do clinicians mean by epidemics' preparedness 48
Outcome of early treatment of SARS‐CoV‐2 infection in patients with haematological disorders 45
Role of liposomal amphotericin B in intensive care unit: an expert opinion paper 45
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 45
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 44
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 43
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 43
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 41
Elevating fungal care: bridging Brazil’s healthcare practices to global standards 40
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions 40
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 39
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 39
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 37
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply 35
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere! 32
Reliable timescale inference of HBV genotype A origin and phylodynamics 31
Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort study 30
Use of Aztreonam-avibactam for infections caused by MBL-producing Enterobacterales 30
Successful treatment and secondary prophylaxis with pritelivir for a recurrent multidrug-resistant herpes simplex virus 1 infection in an allogeneic haematopoietic stem cell transplant recipient 29
European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease 29
Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study 27
Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment 26
Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort 25
Corrigendum to: “Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)” Clinical Microbiology and Infection 26 (2020) 1545–1553 25
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV‐1 infection 24
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 24
Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients 23
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study) 14
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia: external validation with decision curve analysis 14
Anti–Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a “Hit Hard and Fast” Strategy Improve Outcomes? 10
Primary Therapy for Invasive Aspergillosis With Triazoles or L-AmB: A Multicenter Retrospective Study 9
Reply to Comment on “Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of Candida bloodstream infections: A retrospective multicenter cohort study” 9
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study 8
Monotherapy vs. combination therapy for Enterococcus faecalis bacteraemia: a target trial emulation 7
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia—Author's reply 6
Totale 2.833
Categoria #
all - tutte 12.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202323 0 0 0 0 0 0 0 0 0 0 20 3
2023/2024240 13 11 43 8 13 41 12 18 7 17 28 29
2024/2025397 11 0 3 11 14 47 31 21 81 104 31 43
2025/20261.873 126 143 370 115 140 108 317 104 100 120 106 124
2026/2027300 269 31 0 0 0 0 0 0 0 0 0 0
Totale 2.833